The controversial question of how much disease is caused by medical intervention goes to the heart of a social movement within the profession of pharmacy. The fate of “clinical pharmacy” is tied to the ability of pharmacists to detect and correct errors in prescribed medications, a potential source of iatrogenic disease. The dilemma for pharmacists is that documentation of their clinical activities could increase the liability exposure of medical organizations and impugn the reputations of physicians as competent prescribers of drugs. A participant observation study reveals how problems of drug therapy and the work of clinical pharmacists are negotiated within hospital settings.
No takes yet. Share an insight, caveat, or question.
Broadhead et al. (1985) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: